Nurse Practitioner in Naranja, FL Accepting Medicare
3 Nurse Practitioner nurses found. Showing 1 - 3
 Siurky A Cifuentes, ARNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 26085 S Dixie Hwy, Naranja, FL 33032 Phone: 305-685-5688 Fax: 305-258-4264 |
Ange Marie Pompee-synsmir, ARNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 13805 Sw 264th St, Naranja, FL 33032 Phone: 305-258-6813 Fax: 305-257-5971 |
 Alexander Stronach Jones, Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 27032 S Dixie Hwy, Naranja, FL 33032 Phone: 305-246-0240 Fax: 305-246-0194 |
News Archive
Verenium repurchases $28.4 million in outstanding convertible notes
Verenium Corporation, a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that it repurchased $28.4 million in principal amount of its outstanding convertible notes in a series of privately-negotiated transactions.
CASI initiates ENMD-2076 Phase 2 trial in Chinese patients with triple-negative breast cancer
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announces that it has initiated a Phase 2 trial of its target therapy drug candidate ENMD-2076 in triple-negative breast cancer (TNBC) at the Cancer Hospital of Chinese Academy of Medical Sciences in Beijing, China.
Overreacting to a loss can increase your chances of losing again
It's human nature to hate losing. Unfortunately, it's also human nature to overreact to a loss, potentially abandoning a solid strategy and thus increasing your chances of losing the next time around.
New approach could help in treating brain tumors, other rare cancers
Large randomized clinical trials can uncover biomarkers that indicate which cancer treatments are likely to work best for individual patients. But it's been challenging to find these biomarkers in rarer cancers where such robust data aren't available.
› Verified 3 days ago